A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar

A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar

Abstract Background Mass drug administration (MDA) of praziquantel is one of the main control measures against human schistosomiasis. Although there are claims for including pregnant women, infants and children under the age of 5 years in high-endemic regions in MDA campaigns, they are usually not t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniela Fusco, Raphäel Rakotozandrindrainy, Rivo Andry Rakotoarivelo, Mala Rakoto Andrianarivelo, Njary Rakotozandrindrainy, Tahinamandranto Rasamoelina, Dewi Ismajani Puradiredja, Philipp Klein, Karl Stahlberg, Marie Dechenaud, Eva Lorenz, Anna Jaeger, Andrea Kreidenweiss, Pytsje T. Hoekstra, Akim Ayola Adegnika, Elisa Sicuri, Paul L. A. M. Corstjens, Govert J. van Dam, Jürgen May, Norbert Georg Schwarz, on behalf of the freeBILy consortium
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Schistosomiasis
Pregnant women
Children
Mass drug administration
Praziquantel
Point of care-circulating cathodic antigen test
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/639b14698233424bb28438e1ca07d47d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/639b14698233424bb28438e1ca07d47d

Ejemplares similares